Aims A major problem in contemporary therapeutics is to predict those non-antiarrhythmic drugs (nards) which might prolong the QT interval. Block of repolarizing cardiac K + current is the most likely cause of drug-induced QT prolongation. In this paper we compared six members from four important classes of nards, antihistamines, antipsychotics, antibiotics and prokinetics, for their block of the major repolarizing cardiac potassium currents I Kr ,I Ks , I To and I Kur . The currents were produced by heterologous expression of HERG (KCNH2), MinK/KvLQT1 (KCNE1/ KCNQ1), Kv4·3 (KCND3) and Kv1·5 (KCNA5) respectively. To evaluate the effects of different cellular backgrounds HERG was expressed stably in HEK 293 and mouse L cells, and transiently in Xenopus laevis oocytes.
Introduction
QT interval prolongation results from a reduction of repolarizing, outward K + current or an increase of depolarizing, inward Na + current during the cardiac action potential (CAP). Hereditary long QT syndrome (hLQTS) manifests QT prolongation, syncope and sudden cardiac death. This rare genetic disease is heterogeneous and is linked to four K + channel genes, KCNH2 [human ether-à-go-go related gene(HERG [1, 2] )], KCNQ1 (KvLQT1 [3] ), KCNE1 (minK [4] [5] [6] ), KCNE2 (MIRP1 [7] ) and one Na + channel gene SCN5A (cardiac NaCh [8, 9] ). The currents attributed to these gene products are I Kr (HERG), I Ks (KvLOT1/minK) and I Na . Acquired LQTS resembles hLQTS, and is most commonly drug-induced. One category of drugs includes antiarrhythmic drugs (ards) which prolong the CAP and reduce re-entry. Development of ards has declined recently with the realization that their cardiac ion channel targets may be the same as those linked to hLQTS. A second category includes non-antiarrhythmic drugs or nards that have the potential for QT prolongation. This category is increasing with the ever-growing numbers of therapeutic drugs continually introduced by the pharmaceutical industry. At present acquired LQTS (aLQTS) produced by nards appears to be due to block of repolarizing cardiac K + currents especially I Kr the rapid component of the delayed rectifier K + current produced by HERG [10] [11] [12] [13] [14] [15] . A sustained ultra-rapid component I Kur produced by Kv1·5 [16] [17] [18] and expressed primarily in atrial myocytes is also a target [19] [20] [21] [22] , but its contribution to ventricular repolarization and the QT interval is minimal. Other targets would include I Ks , the slow component of the delayed rectifier K + current produced by KvLQT1/minK, and I To the transient outward K + current produced by Kv4·3 [23] [24] [25] [26] . Drugs from four classes of nards have been especially implicated in aLQTS, namely antihistamines, antipsychotics, antibiotics and prokinetics, and members from each class, including terfenadine, astemizole, sertindole and cisapride, have been withdrawn from the market.
Clearly pre-clinical assays that predict nards which may prolong the QT interval are highly desirable. Widely used assays developed before the discovery of the ion channels linked to hLQTS (pre-hLQTS) have included action potential duration measurements in a variety of tissues and species and QT measurements in a variety of anaesthetized and unanaesthetized animals. None of these methods directly measure the cardiac K + channels likely to be targets for nard-induced aLQTS. A step in this direction was taken in the early 1990s when an assay using human Kv1·5 channels was introduced [21] . More recently, assays using cloned K + channels linked to hLQTS have been introduced [10, 14, 27] . However, a systematic comparison of the relative sensitivity of the four most important repolarizing cardiac K + channels, HERG, KvLQT1/minK, Kv4·3 and Kv1·5, to nards has not yet been made, nor has the influence of the cell lines used for channel expression been evaluated. In the present experiments we compared representatives of the four major classes of nards, antihistamines, antipsychotics, antibiotics and prokinetics, for their effects on stable clonal cell lines expressing HERG (I Kr ), KvLQT1/minK (I Ks , Kv4·3(I to ) and Kv1·5 (I Kur ). To evaluate possible influences of the different commonly used heterologous cell systems, HERG was expressed in HEK 293, mouse L cells and Xenopus oocytes. We measured currents with whole cell patch clamp and calculated IC 50 values of block from doseresponse curves at room and body temperatures. For all six of the drugs examined, HERG was the most sensitive target. HERG channels expressed in the different mammalian cell lines had similar IC 50 values. These values were five to one hundred times larger when HERG was expressed transiently in Xenopus oocytes. IC 50 values were temperature-dependent but the effects were small and variable. For nards that have been withdrawn from the drug market, such as terfenadine, astemizole, sertindole and cisapride, the IC 50 values for HERG block correlated with the free serum levels associated with clinical QT prolongation.
Methods

Compounds used and their preparation
All chemicals used in the preparation of bath and electrode solutions were purchased from Sigma (St. Louis, MO) and were at least of ACS reagent grade purity. Drug solutions were prepared by dilution of the stock solution prepared in DMSO using Tyrode's solution. Final DMSO concentrations were not greater than 0·1%. 
Stable expression in mammalian cells
Transient expression in Xenopus oocytes
Stage V-VI Xenopus oocytes were defolliculated by collagenase treatment (2 mg . ml 1 for 1·5 h)inaCa 2+ -free buffer solution containing: NaCl, 82·5 mM; KCl, 2·5 mM; MgCl 2 mM, 1; HEPES, 5 mM; gentamicin, 100 g.ml 1 ; adjusted to pH 7·6 with NaOH. cDNA constructs were linearized for runoff transcription. In vitro transcription was performed using the mMessage Machine kit (Ambion). The amount of cRNA synthesized was quantitated by the incorporation of trace amounts of [ 32 P]UTP in the synthesis mixture. The quality of synthesized cRNA was evaluated by denaturing agarose gel electrophoresis. The cRNAs were diluted to appropriate concentrations immediately before oocyte injection. Electrophysiological measurements were made 3-7 days after cRNA injection with 46 nl of appropriately diluted cRNA. Injected oocytes were maintained at 19 C on the platform of a slowly oscillating orbital shaker in a low temperature incubator until use.
Cell culture
Cells were maintained in water-saturated 95% O 2 /5% CO 2 incubators at 37 C in DMEM culture medium supplemented with 10% fetal bovine serum and 500 g.ml 1 geneticin (G418). The KvLQT1/minK culture media was further supplemented with 700 g.ml 1 zeocin.
Electrophysiological recording and solutions
Mammalian cells were voltage clamped with the wholecell variant of the patch clamp technique. Cells attached to glass coverslips were transferred to the recording chamber and superfused with a modified Tyrode's solution of composition: NaCl, 137 mM; KCl, 5·4 mM; CaCl 2 ,1·8mM; MgCl 2 , 1 mM; HEPES, 5 mM; Glucose, 10 mM; pH adjusted to 7·4 with NaOH. The pipette solution for whole cell recordings was of composition: K-aspartate, 130 mM; MgCl 2 , 5 mM; EGTA, 5 mM; ATP, 4 mM; GTP, 0·1 mM; HEPES, 10 mM; pH adjusted to 7·2 with KOH. In KvLQT 1 /minK experiments the internal solution was supplemented with 14 mM phosphocreatine and 50U.mL 1 creatine phosphokinase. Patch pipettes were fabricated from 7052 or 7740 glass capillaries on a P-97 horizontal puller (Sutter Instruments, CA) to generate pipettes with 1-3 megohm resistances after fire polishing. Axon Instruments (Axon Instruments, Inc., CA) Axopatch 1B or 200B and Warner PC-501A patch clamp amplifiers were used for whole cell patch clamp recordings. Current records were analogue filtered at 0·5 or less of the sampling frequency for digital conversion. Experiments were performed at room and physiological temperatures. Resistive heating temperature regulators (Cell Microcontrols, VA) were used to maintain cells and solutions at physiological temperatures.
Whole cell currents were recorded from oocytes using the conventional two-microelectrode voltage clamp technique. Oocyte voltage clamp current records were obtained with a Warner oocyte clamp (OC-725A), and low pass filtered at 0·5 or less of the sampling frequency for digital conversion. Pipettes were pulled on a Kopf vertical puller from borosilicate glass capillaries. The electrode filling solution consisted of 3 M KCl, 10 mM HEPES and 10 mM EGTA adjusted to pH 7·4 with Tris base. Oocytes were placed in a milled plastic chamber and superfused with Ringer solution containing: NaCl, 120 mM; KCl, 2·5 mM; CaCl 2 ,1 · 1 mM; HEPES, 10 mM; pH adjusted to 7·2 with NaOH. All experiments were performed at room temperature.
Voltage protocols
We used two protocols for measuring the concentrationresponse of HERG. The first protocol (standard protocol) is similar to protocols typically used to measure HERG current responses. The cell was held at 80mV and a step to +40 mV (400 ms) was followed by a step to 50 mV (400 ms) to generate a tail current. This protocol was repeated at 10-s intervals during application of the drug. An alternative protocol (conservative protocol) to increase the magnitude of current responses and achieve steady-state activation of channels was also used. Cells stably expressing HERG were held at 0 mV. Onset and steady state of the block were monitored by using a pulse pattern with fixed amplitudes (hyperpolarization: 80 mV (20 ms); depolarization: +40 mV (80 ms)) repeated at 10-s intervals during application of the drug. When a steady state was attained, drug effects were measured.
Use-dependence
The standard protocol was modified to reduce the duration of the voltage steps. The cell was held at 80 mV and a step to +40 mV (200 ms) was followed by a step to 50 mV (50 ms) to generate a tail current. The alternative protocol was unchanged. Cells expressing HERG were held at 0 mV for at least 1 min and then a train of pulses sufficient to reach a steady state value (typically in the range of 20-30 pulses) were applied at frequencies of 0·1 and 3 Hz (nd2). Drug effects are measured after equilibration of drug with the channel at concentrations near the IC 50 for the compound. Onset of the block was monitored by using a pulse pattern with fixed amplitudes (hyperpolarization: 80 mV for 20 ms; depolarization: +40 mV for 80 ms). Block was determined to have reached a steady state when the rate of change of current became constant.
Temperature-dependence
The protocols used for obtaining concentrationresponse relations were used to measure block near the IC 50 at physiological temperatures (32-37 C).
Results
Comparison of nard block among cardiac repolarizing K + currents
The four repolarizing K + channels of interest, HERG, KvLQT1/minK, Kv1·5 and Kv4·3, and their relationships to the cardiac action potential are shown in Fig. 1 . The four channels were expressed in the same background of mammalian cells and drug block was compared among them. A comparison of the IC 50 values for representative nards is shown in Table 1 . For all six of the drugs tested HERG was the most sensitive target. Cloned HERG IC 50 values were similar to values reported earlier for sertindole and risperidone, erythromycin and cisapride [28] . A comparison of the dose-response curves of all four K + channels is shown in Fig. 2 . Each drug blocked all four channels in a concentration-dependent manner. In all but one case the binding could be fit with a single-site binding curve. The low nanomolar IC 50 for block of HERG by terfenadine (Table 1) is consistent with reports for block by this agent of native I Kr [29] in ventricular myocytes and/or block of the primary H 1 
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Eur Heart J Supplements, Vol. 3 (Suppl K) September 2001 receptor in guinea-pig ileum [30] . Block of HERG by fexofenadine, the carboxylated metabolite of terfenadine, was similar to values reported by Rampe [31] .
The nanomolar IC 50 values for block by risperidone and sertindole are consistent with other reports [13] . Table  2 shows a comparison with block of HERG (I Kr ) and primary tissue targets which in this case were the septahelical D 2 and 5HT receptors. The IC 50 for block of HERG by erythromycin was similar to a value reported previously [32] . We found that the prokinetic drug cisapride blocked clonal HERG with a nanomolar IC 50 similar to the value reported for HERG expressed in mouse L cells [14] . 
Nature of high affinity block
The effects of sertindole on HERG currents shown in Fig. 3 were representative of those observed for all of the nanomolar IC 50 blockers. Block of resting channels exposed to drug was not apparent. Block became apparent using pulses at 0·1 Hzo f1 -2-s duration and was time-independent showing a simple scaling down of current (Fig. 3A) . The block was greater at higher concentrations and the concentration-response curve was fitted by a one to one binding model (Fig. 3B ). For 5-s pulses, observations of the time-dependence of block were consistent with slow equilibration between the high affinity drug and the activated channel [13] . In the sertindole experiments in Table 1 we used the conservative voltage protocol described in Methods which maximized the activated state of HERG channels. We have compared the IC 50 value obtained by this method with that obtained by the more customary protocol used in other reports and found that the differences were not significant (customary protocol IC 50 :1 · 58 nM; conservative voltage protocol IC 50 : 5 nM).
Temperature-dependence of block
Experiments to this point had been done at room temperatures of 20-24 C. Room temperature was preferred to the physiological temperature of 37 C because it is tolerated much better by the clonal cell lines and by native I Kr . Therefore it was important to test the effects of temperature on IC 50 values and we did so for several drugs including loratadine. We compared the concentration-response curves and IC 50 values for terfenadine at 22 and 35 C and found a small increase at the higher temperature (Fig. 4) . Similar small changes were found for erythromycin and cisapride and the direction of the changes was variable (data not shown).
Frequency-dependence of block
We found that drug block of all of the clonal K + channels we studied could be enhanced when the frequency of stimulation was increased from 0·1t o1H z . Sample data from Kv1·5 are shown in Fig. 5 .
Comparison of drug block among different heterologous expression systems
We found that drug block was similar for HERG ( Fig. 6A) and Kv1·5 (Fig. 6B ) expressed in mouse L cells 
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Discussion
HEK 293 and mouse L cells have very different cellular genomes into which transfected HERG or Kv1·5 cDNA is incorporated yet these differences do not significantly affect the sensitivity of clonal HERG or clonal Kv1·5 channels to nards. Thus clonal Kv current assays are robust indicators of drug sensitivity, as might be expected from the dominance of these currents resulting from overexpression, no matter which cell line was used. The nards we tested preferentially blocked activated channels. It was expected that pulse protocols that favoured activated states more strongly would enhance sensitivity, but our results were not significant in this regard. Frequency dependence should occur when the rates of stimulation overlap with the rates of drug interaction with target ion channel and we found this to be the case in the present experiments. Temperature dependence was unpredictable but was not a significant factor in the present experiments.
Significance of clonal HERG block for QT prolongation
Our IC 50 values for block of clonal HERG agree in general with those published for native I Kr . This result suggests that cellular modifiers of HERG in native cells from a variety of species do not significantly affect outcomes. MinK [33] and MiRP1 [7] have been shown to interact with HERG in overexpression experiments but neither has been shown to co-immunoprecipitate with HERG in cardiac tissue. MiRP1 has been linked to hLQTS and appears to have altered clarithromycin sensitivity to HERG but the significance of this finding to the clonal assay system has yet to be determined.
IC 50 values for primary nard targets determine the dosage regimen and serum levels necessary for efficacy.
The relative values of these IC 50 s will determine the likelihood of HERG block and QT prolongation. One caveat to this interpretation is the finding, which we have confirmed, that verapamil blocks HERG but does not prolong QT. The explanation lies in the fact that verapamil blocks inward current, in this case calcium current, thereby offsetting the effect of HERG block on outward repolarizing current. Results with clonal HERG or native I Kr need to be interpreted with similar caveats in mind. Of the nards that have been withdrawn (terfenadine, sertindole and cisapride) the ratio between IC 50 values for clonal HERG or native I Kr and IC 50 for the primary target or serum concentrations for drug efficacy, which may be a safety ratio, was between 0·1 and 0·01. It would appear that safety ratios less than 0·01 might provide a basis for risk/benefit assessments of nards.
HERG sensitivity to nards
Our results show that HERG is the repolarizing cardiac K + channel that is the most sensitive to nards that have prolonged QT. Given the sensitivity of HERG to numerous diverse nards, we carried out negative controls with atropine and TEA. We found that atropine produced a very low affinity block with an IC 50 of 558 nM (n=4). Our positive control in these experiments was dofetilide which blocked with an IC 50 of 15 nM (n=5) similar to reports in the literature [34, 35] . Why HERG should be so sensitive to nards is unknown. Within the antihistamine class of nards, the polarity-aromaticity of the side chains linked to the tertiary amine nitrogen atom explain the differences in affinity between terfenadine and fexofenadine, astemizole and norastemizole and terfenadine/ astemizole and loratadine [36] [37] [38] . The aromatic F656 in S6 of HERG may be important for these nards as it is for methanesulfonanilide block [39] . Another factor in HERG sensitivity may be related to the fact that HERG has the most unique gating of any voltage-dependent K + channel. In HERG, inactivation rates approach activation rates at more depolarized potentials thereby producing inward rectification and removal of inactivation is faster than deactivation at hyperpolarized potentials. Perhaps the conformational changes associated with the gating provide unique opportunities for strong binding of drugs as diverse in structure as the ones we have studied presently.
Comparison among pre-clinical assays for predicting QT prolongation
Four different pre-clinical assays are available: (1) clonal ion channel currents; (2) membrane currents in native cardiomyocytes; (3) action potential durations in native cardiac tissue; and (4) QT prolongation in anaesthetized or conscious animals. Torsadegenic models are not considered here because experience with them is very limited so far. These assays progress from lower (1) to higher (2-4) levels, i.e. from molecular through cellular to whole animal. At the molecular level the assays are defined and are made relevant by linkage with human QT prolongation of hLQTS and, as experience accumulates, of aLQTS. As shown here, drugs in each class of nards that prolong QT have affinities for HERG that overlap with affinities for their primary target and therefore the therapeutic concentrations that are achieved. At higher levels the assays are less well defined and more complex. For assays 1 and 2 both inward and outward cardiac currents ( Fig. 1 ) are in theory candidates and the channels that might be tested include cardiac sodium and calcium channels, HERG, KvLQT1/minK, Kv4·3 and Kv1·5. In practice, however, the vast majority of nards act on repolarizing K + currents, in particular HERG and to a lesser extent KvLQT1/minK, as shown here, and potentially Kv4·3 and Kv1·5 in assay 1. These clonal measurements correspond to measurements of I Kr ,I Ks ,I to , and I Kur in assay 2. The advantage of assay 1 over assay 2 is that the clonal systems are defined by the cDNAs that have been added. Moreover the clones express the human channels of interest or animal channels that have been selected because they are highly homologous to the human channel. In contrast, the currents of primary interest in native cells must be isolated from all other membrane currents by pharmacological or functional methods which may be incomplete. Moreover native cells must be selected from tissues and species that express the currents of interest. For example, rat ventricular and human atrial myocytes do not express significant I Kr or I Ks , while guinea-pig ventricular myocytes do not express significant I to .
Assays 3 and 4, although poorly defined, are more closely associated with the QT interval of the human ECG. Thus the false positive from verapamil in assays 1 and 2 would not be detected in assays 3 and 4. However species differences may produce false negatives, as in the case of terfenadine which did not prolong the QT interval in dogs. To conclude, no single pre-clinical assay is a perfect predictor of human QT prolongation and some combination of molecular and higher level assay seems to be the best approach for identifying nards that may produce QT prolongation.
